Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3258 (117th)

TACT Act of 2021

referredUnited States· United States Congress· EN

Introduced

14 May 2021

Last action

17 May 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Sewell, Terri A. [D-AL-7], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Rutherford, John H. [R-FL-5], Rep. Joyce, John [R-PA-13], Rep. Comer, James [R-KY-1], Rep. Lucas, Frank D. [R-OK-3], Rep. Wild, Susan [D-PA-7], Rep. DelBene, Suzan K. [D-WA-1], Rep. DeGette, Diana [D-CO-1], Rep. Khanna, Ro [D-CA-17], Rep. Zeldin, Lee M. [R-NY-1], Rep. Stansbury, Melanie A. [D-NM-1], Rep. Babin, Brian [R-TX-36], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Cammack, Kat [R-FL-3]

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021 This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames. Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization. Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing. The Government Accountability Office must evaluate and report on the implementation of these requirements.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 May 2021

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 14 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 14 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 17 May 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 14 May 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 14 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 14 May 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.